Tirzepatide is a novel medication developed for the treatment of type 2 diabetes and obesity. It belongs to a new class of drugs called dual GLP-1 and GIP receptor agonists (also referred to as “twincretins”). Tirzepatide simultaneously activates two incretin hormone receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), both of which play crucial roles in regulating blood sugar and metabolism.
Original price was: $450.00.$325.00Current price is: $325.00.
Peptides will arrive in a lyophilized (powder) form for maximum stability
9 in stock
Original price was: $450.00.$325.00Current price is: $325.00.
Original price was: $450.00.$325.00Current price is: $325.00.
9 in stock
Receive all the latest information on events, sales, & offers.
info@peptidessource.com
Mon - Fri / Except Holidays
Orders placed and paid after 12 PM PST are shipped the following business day
P-Sciences
Philadelphia, PA 19152
© 2025
peptidesciences.is. All Rights Reserved.
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Peptide Sciences is a chemical supplier. Peptide Sciences is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Peptide Sciences is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.